These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

663 related items for PubMed ID: 32592843

  • 1. Clinical characteristics and outcome in patients with combined diabetic ketoacidosis and hyperosmolar hyperglycemic state associated with COVID-19: A retrospective, hospital-based observational case series.
    Chan KH, Thimmareddygari D, Ramahi A, Atallah L, Baranetsky NG, Slim J.
    Diabetes Res Clin Pract; 2020 Aug; 166():108279. PubMed ID: 32592843
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [The Management of Blood Glucose Should be Emphasized in the Treatment of COVID-19].
    Ma WX, Ran XW.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 Mar; 51(2):146-150. PubMed ID: 32220179
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pediatric Diabetic Ketoacidosis With Hyperosmolarity: Clinical Characteristics and Outcomes.
    Agrawal S, Baird GL, Quintos JB, Reinert SE, Gopalakrishnan G, Boney CM, Topor LS.
    Endocr Pract; 2018 Aug; 24(8):726-732. PubMed ID: 30084686
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A UK nationwide study of adults admitted to hospital with diabetic ketoacidosis or hyperosmolar hyperglycaemic state and COVID-19.
    Field BCT, Ruan Y, Várnai KA, Davies J, Ryder REJ, Gandhi R, Harris S, Nagi D, Patel D, Kempegowda P, Wild SH, Wilmot EG, Khunti K, Rea R, Narendran P, ABCD COVID-19 Audit Group.
    Diabetes Obes Metab; 2023 Jul; 25(7):2012-2022. PubMed ID: 37016487
    [Abstract] [Full Text] [Related]

  • 15. Some characteristics of hyperglycaemic crisis differ between patients with and without COVID-19 at a safety-net hospital in a cross-sectional study.
    Shah A, Deak A, Allen S, Silfani E, Koppin C, Zisman-Ilani Y, Sirisena I, Rose C, Rubin D.
    Ann Med; 2021 Dec; 53(1):1642-1645. PubMed ID: 34511013
    [Abstract] [Full Text] [Related]

  • 16. High prevalence of COVID-19-associated diabetic ketoacidosis in UK secondary care.
    Goldman N, Fink D, Cai J, Lee YN, Davies Z.
    Diabetes Res Clin Pract; 2020 Aug; 166():108291. PubMed ID: 32615280
    [Abstract] [Full Text] [Related]

  • 17. Clinical profile and outcomes in COVID-19 patients with diabetic ketoacidosis: A systematic review of literature.
    Pal R, Banerjee M, Yadav U, Bhattacharjee S.
    Diabetes Metab Syndr; 2020 Aug; 14(6):1563-1569. PubMed ID: 32853901
    [Abstract] [Full Text] [Related]

  • 18. Combined diabetic ketoacidosis and hyperosmolar hyperglycemic state in type 1 diabetes mellitus induced by immune checkpoint inhibitors: Underrecognized and underreported emergency in ICIs-DM.
    Zhang W, Chen J, Bi J, Ding N, Chen X, Wang Z, Jiao Y.
    Front Endocrinol (Lausanne); 2022 Aug; 13():1084441. PubMed ID: 36686495
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Baseline characteristics and risk factors for short-term outcomes in 132 COVID-19 patients with diabetes in Wuhan China: A retrospective study.
    Li Y, Han X, Alwalid O, Cui Y, Cao Y, Liu J, Gu J, Wang L, Fan Y, Shi H.
    Diabetes Res Clin Pract; 2020 Aug; 166():108299. PubMed ID: 32623030
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.